These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33770730)
1. Oridonin ameliorates noise-induced hearing loss by blocking NLRP3 - NEK7 mediated inflammasome activation. Li M; Zhang Y; Qiu S; Zhuang W; Jiang W; Wang C; Zhang S; Zhou Z; Sun T; Ke Z; Guo W; Qiao Y; Shi X Int Immunopharmacol; 2021 Jun; 95():107576. PubMed ID: 33770730 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors. Zhao N; Li CC; Di B; Xu LL J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754 [TBL] [Abstract][Full Text] [Related]
3. NEK7 mediated assembly and activation of NLRP3 inflammasome downstream of potassium efflux in ventilator-induced lung injury. Liu H; Gu C; Liu M; Liu G; Wang Y Biochem Pharmacol; 2020 Jul; 177():113998. PubMed ID: 32353421 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7. Kim SK; Choe JY; Park KY Biochem Biophys Res Commun; 2019 Sep; 517(2):338-345. PubMed ID: 31358323 [TBL] [Abstract][Full Text] [Related]
5. Hit-to-Lead Optimization of the Natural Product Oridonin as Novel NLRP3 Inflammasome Inhibitors with Potent Anti-Inflammation Activity. He C; Liu J; Li J; Wu H; Jiao C; Ze X; Xu S; Zhu Z; Guo W; Xu J; Yao H J Med Chem; 2024 Jun; 67(11):9406-9430. PubMed ID: 38751194 [TBL] [Abstract][Full Text] [Related]
6. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. He H; Jiang H; Chen Y; Ye J; Wang A; Wang C; Liu Q; Liang G; Deng X; Jiang W; Zhou R Nat Commun; 2018 Jun; 9(1):2550. PubMed ID: 29959312 [TBL] [Abstract][Full Text] [Related]
7. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice. Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408 [TBL] [Abstract][Full Text] [Related]
8. Oridonin employs interleukin 1 receptor type 2 to treat noise-induced hearing loss by blocking inner ear inflammation. Chen MB; Li MH; Wu LY; Wang R; Long X; Zhang L; Sun W; Guo WW; Pan Y; Zhang YS; Lin C; Shi X; Yang SM Biochem Pharmacol; 2023 Apr; 210():115457. PubMed ID: 36806583 [TBL] [Abstract][Full Text] [Related]
9. Oridonin ameliorates insulin resistance partially through inhibition of inflammatory response in rats subjected to chronic unpredictable mild stress. Liang L; Zheng Y; Xie Y; Xiao L; Wang G Int Immunopharmacol; 2021 Feb; 91():107298. PubMed ID: 33388733 [TBL] [Abstract][Full Text] [Related]
10. NEK7-Mediated Activation of NLRP3 Inflammasome Is Coordinated by Potassium Efflux/Syk/JNK Signaling During Liu R; Liu Y; Liu C; Gao A; Wang L; Tang H; Wu Q; Wang X; Tian D; Qi Z; Shen Y Front Immunol; 2021; 12():747370. PubMed ID: 34603335 [No Abstract] [Full Text] [Related]
11. The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia-reperfusion injury. Xu KY; Wu CY; Tong S; Xiong P; Wang SH Biochem Biophys Res Commun; 2018 Sep; 503(4):3031-3037. PubMed ID: 30146255 [TBL] [Abstract][Full Text] [Related]
12. Oridonin alleviates kanamycin-related hearing loss by inhibiting NLRP3/caspase-1/gasdermin D-induced inflammasome activation and hair cell pyroptosis. Wu L; Chen M; Li M; Wang Y; Li Y; Zheng L; Ke Z; Liu K; Qiao Y; Shi X Mol Immunol; 2022 Sep; 149():66-76. PubMed ID: 35749835 [TBL] [Abstract][Full Text] [Related]
13. NEK7: a potential therapy target for NLRP3-related diseases. Liu G; Chen X; Wang Q; Yuan L Biosci Trends; 2020 May; 14(2):74-82. PubMed ID: 32295992 [TBL] [Abstract][Full Text] [Related]
14. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. He Y; Zeng MY; Yang D; Motro B; Núñez G Nature; 2016 Feb; 530(7590):354-7. PubMed ID: 26814970 [TBL] [Abstract][Full Text] [Related]
15. PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome. Yang XD; Li W; Zhang S; Wu D; Jiang X; Tan R; Niu X; Wang Q; Wu X; Liu Z; Chen LF; Qin J; Su B EMBO J; 2020 Jan; 39(2):e102201. PubMed ID: 31762063 [TBL] [Abstract][Full Text] [Related]
16. Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases. Fang ZE; Wang Y; Bian S; Qin S; Zhao H; Wen J; Liu T; Ren L; Li Q; Shi W; Zhao J; Yang H; Peng R; Wang Q; Bai Z; Xu G Phytomedicine; 2024 Jan; 122():155159. PubMed ID: 37931457 [TBL] [Abstract][Full Text] [Related]
17. Assessment of NLRP3 Inflammasome Activation and NLRP3-NEK7 Complex Assembly. Kelley N; He Y Methods Mol Biol; 2023; 2641():17-26. PubMed ID: 37074638 [TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages. Shi Y; Lv Q; Zheng M; Sun H; Shi F Int Immunopharmacol; 2021 Mar; 92():107358. PubMed ID: 33508701 [TBL] [Abstract][Full Text] [Related]
19. PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature. Liu L; Jiang Y; Steinle JJ Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):14. PubMed ID: 35006270 [TBL] [Abstract][Full Text] [Related]
20. NIMA-related kinase 7 amplifies NLRP3 inflammasome pro-inflammatory signaling in microglia/macrophages and mice models of spinal cord injury. Ji X; Song Z; He J; Guo S; Chen Y; Wang H; Zhang J; Xu X; Liu J Exp Cell Res; 2021 Jan; 398(2):112418. PubMed ID: 33309808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]